The dispute revolves around Sun Pharma’s allegation that Rambos Lifesciences adopted and marketed pharmaceutical products under the marks URSOCAL and URSOCAL-300, which are “deceptively similar” to its well-established brand URSOCOL. Sun Pharma argued that such similarity was likely to create confusion among doctors, chemists, and patients in the sensitive pharmaceutical sector.
Hearing the matter, Justice Arif S Doctor, through an order dated 20 August 2025, categorically restrained Rambos and its associates from infringing Sun Pharma’s rights. The Court observed that confusion in medicinal products could have serious consequences and therefore warranted urgent protection.
The Court held:
“That pending the hearing and final disposal of the suit, the Respondents … be restrained by a temporary order and injunction of this Hon'ble Court from infringing the Applicant's registered trade mark 'URSOCOL' bearing registration no.1119429 in class 5, by the use of the impugned trade mark 'URSOCAL' and/or 'URSOCAL-300' and/or any other trademark containing the word 'URSOCAL' and/or any other trade mark identical with and/or deceptively similar to the Applicant's said registered trade mark.”
Earlier, on 16 July 2025, the Court had appointed the Court Receiver with wide powers to take possession of infringing goods, packaging materials, and related documents from the Respondents.
The order stated,
"That pending the hearing and final disposal of the suit, the Respondents by themselves, through their promotors, proprietors, Meera Jadhav 3/3 17-iaL-20229-25.doc partners, directors, affiliates, associate/s, sister/group companies, employees, manufacturers, servants, agents, stockists, super- stockiest, e-commerce and warehouse aggregators, distributors, purchasers, dealers, franchisees, licensees, assigns, wholesalers, retailers, custodians, importers, exporters, predecessors, successors and all persons claiming through and/or under them or acting on their behalf or connected with them in their business be restrained by a temporary order and injunction of this Hon'ble Court from infringing the Applicant's said registered trade mark 'URSOCOL' bearing registration no.1119429 in class 5, by the use of the impugned trade mark 'URSOCAL' and/or 'URSOCAL-300'and/or any other trademark containing the word 'URSOCAL' and/or any other trade mark identical with and/or deceptively similar to the Applicant's said registered trade mark bearing no.1119429 in class 5 in respect of the goods covered by the Applicant's said registration or like goods or in any other manner whatsoever."
This order was executed on 6 August 2025, and the Court Receiver filed Report No. 371 of 2025 outlining the steps taken.
Recording this, the Court adjourned the matter to 29 August 2025, as service on Defendant No.1 was noted to be incomplete.
The matter remains sub judice, and the interim relief continues to operate until final adjudication
To view the official order, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.